FDA Eases Requirements for Repackaging of Propofol

In an emergency final guidance released yesterday, the FDA agency said it is temporarily relaxing its regulations for repackaging and combining units of propofol during the COVID-19 pandemic.
Source: Devices & Diagnostics Letter